Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients
Ophthalmology, 04/27/2012
Clinical Article
Diaz–Llopis M et al. – Adalimumab seems to be well tolerated and helpful in decreasing inflammatory activity in refractory uveitis and may reduce steroid requirement.



